Pharmamarketeer

European Commission approves Bristol─Myers Squibb’s pending acquisition of Celgene

Bristol─Myers Squibb Company announced that the European Commission (EC) has granted unconditional approval of Bristol─Myers Squibb’s pending acquisition of Celgene Corporation.

Advertentie(s)
Geen nieuws missen?
Volg de duizenden farma professionals die Pharmamarkteer.nl via e-mail lezen

Uw inschrijving is gelukt.
Bedankt!
Naar Pharmamarkteer.nl